International IPO

International IPO

SharonAI Files for NASDAQ IPO: Can This AI High-Performance Compute Provider Win Wall Street?

SharonAI Holdings, Inc. files an S-1 registration statement for a NASDAQ IPO. Explore its GPU AI cloud compute platform, market trends, and SWOT.

International IPO

Attovia Therapeutics Lists on NASDAQ under Ticker ATTO: Is This Biparatopic Biotech Worth Bidding?

Attovia Therapeutics (NASDAQ: ATTO) debuts raising $200 Million. Discover its biparatopic antibody platform, clinical trial timelines, and SWOT analysis.

International IPO

Attovia Therapeutics IPO: Can This $200M Biotech Debut Spark NASDAQ Growth?

Clinical-stage biopharmaceutical company Attovia Therapeutics files for NASDAQ IPO under ticker ATTO to raise up to $200 Million. Discover its drug pipelines and target valuation.

International IPO

Londian Wason Files for NYSE IPO under Ticker FOIL: Can This EV Battery Supplier Spark Wall Street?

Londian Wason files for NYSE IPO under ticker FOIL to raise $78.6 Million. Discover the price band, valuation, and battery-grade copper foil manufacturing SWOT.

International IPO

Reformation IPO Prices at $15: Can Sustainable Fashion Win on Wall Street?

Sustainable fashion pioneer Reformation prices its NYSE IPO at $15 per share. Analyze the brand's growth SWOT, retail expansion plans, and valuation metrics.

International IPO

Jersey Mike’s Files for IPO: Is This Fast-Casual Sandwich Giant Worth Your Bid?

Fast-casual sandwich giant Jersey Mike's files for its IPO under ticker JMKE. Analyze its franchise model, growth SWOT, and valuation prospects before it lists.

International IPO

Ionic Digital Files for Nasdaq IPO: Can the Celsius Bankruptcy Spin-Off Deliver Real Gains?

Bitcoin miner Ionic Digital, formed from the Celsius Network bankruptcy exit, files for its Nasdaq IPO under ticker IOND. Review its infrastructure and SWOT.

International IPO

Sleep Apnea Drug Developer Apnimed Files for Nasdaq IPO Following FDA Acceptance

Clinical-stage biotechnology firm Apnimed has submitted its S-1 prospectus for a Nasdaq IPO following FDA acceptance of its New Drug Application for sleep apnea oral treatment Oxnimbi.

International IPO

London Stock Market Bounces Back with New Beauty and Consumer Brand IPO Listings

The London Stock Exchange (LSE) is showing signs of recovery in listing activity, with a major beauty group and a consumer brand confirming prospectus filings for the second half of 2026.

International IPO

OpenAI Files Confidentially for Initial Public Offering on US Stock Market

Artificial intelligence pioneer OpenAI has reportedly filed confidential draft papers for a US initial public offering (IPO), targeting listing gains and seeking capital to fund massive AGI infrastructure.